am.lundgren
Submits third-party assay reports on material purchased directly. Based in Aarhus.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.84%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042912 | Retatrutide | GGPeps | GGPE-2604-X2191 | Janoshik | 2026-Q2 | 98.23 | 5.04 | 95.9 | Buyer-sourced | 1 | FAIL |
| AX-2026-042241 | Tirzepatide | Homopeptide | HOMO-2601-N1343 | Nordanalyt | 2026-Q2 | 98.84 | 5.57 | 88.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042617 | MGF | SWB | SWB-2601-E7244 | Kestrel | 2026-Q1 | 98.84 | 5.09 | 102.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043058 | Melanotan II | MKM | MKM-2508-B4171 | Janoshik | 2025-Q4 | 98.74 | 2.66 | 92.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019342 | Selank | TFC | TFC-2511-C7705 | VendorInvestigate | 2025-Q4 | 99.93 | 8.49 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020182 | Semaglutide | GGPeps | GGPE-2501-W9913 | PeptideMeter | 2025-Q1 | 98.34 | 5.47 | 105.3 | Buyer-sourced | 0 | PASS |
| AX-2024-004460 | MOTS-c | FGP | FGP-2411-A1090 | Janoshik | 2024-Q4 | 99.65 | 5.56 | 98.2 | Buyer-sourced | 0 | PASS |
| AX-2024-005208 | Ipamorelin | KP | KP-2407-H6541 | Janoshik | 2024-Q3 | 99.81 | 3.09 | — | Laboratory-retained | 0 | PASS |